XML 29 R18.htm IDEA: XBRL DOCUMENT v3.10.0.1
Earnings Per Common Share
9 Months Ended
Sep. 30, 2018
Earnings Per Common Share  
Earnings Per Common Share

Note 10:  Earnings Per Common Share

 

Earnings per common share have been computed as follows (in thousands, except per share data):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

September 30, 

 

September 30, 

 

 

    

2018

    

2017

    

2018

    

2017

 

Net income available to common stockholders

 

$

26,859

 

$

18,784

 

$

73,638

 

$

50,433

 

Shares:

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding

 

 

48,892

 

 

45,324

 

 

48,828

 

 

40,669

 

  Dilutive effect of outstanding options, warrants and restricted 

     stock units as determined by the application of the treasury

     stock method

 

 

355

 

 

440

 

 

388

 

 

400

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding, as adjusted for

  diluted earnings per share calculation

 

 

49,247

 

 

45,764

 

 

49,216

 

 

41,069

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic earnings per common share

 

$

0.55

 

$

0.41

 

$

1.51

 

$

1.24

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per common share

 

$

0.55

 

$

0.41

 

$

1.50

 

$

1.23

 

 

Basic earnings per share are computed by dividing net income available to common stockholders for the period by the weighted average number of common shares outstanding, which include deferred stock units that are vested but not delivered.

 

Diluted earnings per common share are computed using the treasury stock method and reflect the potential dilution that could occur if the Company’s outstanding stock options and warrants were exercised and restricted stock units were vested.  Stock options, warrants and restricted stock units for which the exercise or the grant price exceeds the average market price over the period have an anti-dilutive effect and are excluded from the calculation. At September 30, 2018,  172,571 outstanding restricted stock units and 191,278 warrants were anti-dilutive and excluded from the calculation of common stock equivalents. At September 30, 2017, 78,540 outstanding options and 191,278 warrants were anti-dilutive and excluded from the calculation of common stock equivalents.